Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy Through the Modulation of Signal Transduction Pathways

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jun 10

PMID 37298670

Authors

Saleh A Almatroodi

Ahmad Almatroudi

Amjad Ali Khan

Arshad Husain Rahmani

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the main causes of death in all developed and developing countries. Various factors are involved in cancer development and progression, including inflammation and alterations in cellular processes and signaling transduction pathways. Natural compounds have shown health-promoting effects through their antioxidant and anti-inflammatory potential, having an important role in the inhibition of cancer growth. In this regard, formononetin, a type of isoflavone, plays a significant role in disease management through the modulation of inflammation, angiogenesis, cell cycle, and apoptosis. Furthermore, its role in cancer management has been proven through the regulation of different signal transduction pathways, such as the signal transducer and activator of transcription 3 (STAT 3), Phosphatidyl inositol 3 kinase/protein kinase B (PI3K/Akt), and mitogen activating protein kinase (MAPK) signaling pathways. The anticancer potential of formononetin has been reported against various cancer types, such as breast, cervical, head and neck, colon, and ovarian cancers. This review focuses on the role of formononetin in different cancer types through the modulation of various cell signaling pathways. Moreover, synergistic effect with anticancer drugs and methods to improve bioavailability are explained. Thus, detailed studies based on clinical trials are required to explore the potential role of formononetin in cancer prevention and treatment.

Citing Articles

Using the Cocrystal Approach as a Promising Drug Delivery System to Enhance the Dissolution and Bioavailability of Formononetin Using an Imidazole Coformer.

Kim J, Lim S, Kim M, Ban E, Kim Y, Kim A Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598356 PMC: 11597446. DOI: 10.3390/ph17111444.

Heterocyclic phytometabolites formononetin and arbutin prevent oxidative and alkylation-induced mutagenicity.

Santos L, Galvao B, Souza L, Fernandes A, Araujo-Lima C, Felzenszwalb I Toxicol Rep. 2024; 13:101753.

PMID: 39434863 PMC: 11492619. DOI: 10.1016/j.toxrep.2024.101753.

Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

Xie D, Jiang Y, Wang H, Zhu L, Huang S, Liu S Front Pharmacol. 2024; 15:1441105.

PMID: 39399463 PMC: 11470441. DOI: 10.3389/fphar.2024.1441105.

Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications.

Zhang J, Wu Y, Tian Y, Xu H, Lin Z, Xian Y Mol Cancer. 2024; 23(1):217.

PMID: 39354520 PMC: 11443726. DOI: 10.1186/s12943-024-02135-3.

Potential Antidiabetic, Antioxidative and Antiproliferative Properties of Functional Wheat Flour Muffins Enriched with White Clover Flowers ( L.).

Borczak B, Szewczyk A, Domagala D, Kapusta-Duch J, Leszczynska T, Kotula M Int J Mol Sci. 2024; 25(18).

PMID: 39337397 PMC: 11432339. DOI: 10.3390/ijms25189909.

References

Chen J, Zeng J, Xin M, Huang W, Chen X . Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res. 2011; 43(10):681-6. DOI: 10.1055/s-0031-1286306. View

Wang A, Li Y, Zhao Q, Fan L . Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways. Mol Med Rep. 2018; 17(6):7721-7729. PMC: 5983960. DOI: 10.3892/mmr.2018.8857. View

Atkinson C, Compston J, Day N, Dowsett M, Bingham S . The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2004; 79(2):326-33. DOI: 10.1093/ajcn/79.2.326. View

Xiong W, Lan Q, Liang X, Zhao J, Huang H, Zhan Y . Cartilage-targeting poly(ethylene glycol) (PEG)-formononetin (FMN) nanodrug for the treatment of osteoarthritis. J Nanobiotechnology. 2021; 19(1):197. PMC: 8254262. DOI: 10.1186/s12951-021-00945-x. View

Curran S, Murray G . Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000; 36(13 Spec No):1621-30. DOI: 10.1016/s0959-8049(00)00156-8. View

Guo Y, Wang Y, Xin M . Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression. Pharm Biol. 2016; :1-6. DOI: 10.3109/13880209.2015.1129546. View

Park S, Bazer F, Lim W, Song G . The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation. J Cell Biochem. 2018; 119(9):7377-7387. DOI: 10.1002/jcb.27041. View

Wang Y, Zhu Y, Gao L, Yin H, Xie Z, Wang D . Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells. Molecules. 2012; 17(9):10052-64. PMC: 6268495. DOI: 10.3390/molecules170910052. View

Nestel P, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron J . Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab. 1999; 84(3):895-8. DOI: 10.1210/jcem.84.3.5561. View

10.

Zhang J, Liu L, Wang J, Ren B, Zhang L, Li W . Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells. J Ethnopharmacol. 2018; 221:91-99. DOI: 10.1016/j.jep.2018.04.014. View

11.

Pal A, Kundu R . Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol. 2020; 10:3116. PMC: 6985034. DOI: 10.3389/fmicb.2019.03116. View

12.

Li S, Li J, Fan Y, Huang T, Zhou Y, Fan H . The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology. Biomed Pharmacother. 2022; 153:113418. DOI: 10.1016/j.biopha.2022.113418. View

13.

Li K, Shen H, Lu M, Chen J, Yin Q, Li P . Formononetin inhibits osteosarcoma cell proliferation and promotes apoptosis by regulating the miR-214-3p/phosphatase and tensin homolog pathway. Transl Cancer Res. 2022; 9(8):4914-4921. PMC: 8798639. DOI: 10.21037/tcr-20-2296. View

14.

Plotnikov A, Flores K, Maik-Rachline G, Zehorai E, Kapri-Pardes E, Berti D . The nuclear translocation of ERK1/2 as an anticancer target. Nat Commun. 2015; 6:6685. DOI: 10.1038/ncomms7685. View

15.

Ritter J, Bielack S . Osteosarcoma. Ann Oncol. 2010; 21 Suppl 7:vii320-5. DOI: 10.1093/annonc/mdq276. View

16.

Anderson M . Update on Survival in Osteosarcoma. Orthop Clin North Am. 2015; 47(1):283-92. DOI: 10.1016/j.ocl.2015.08.022. View

17.

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

18.

Littlepage L, Sternlicht M, Rougier N, Phillips J, Gallo E, Yu Y . Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res. 2010; 70(6):2224-34. PMC: 2840052. DOI: 10.1158/0008-5472.CAN-09-3515. View

19.

Koul H, Pal M, Koul S . Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer. 2013; 4(9-10):342-59. PMC: 3863344. DOI: 10.1177/1947601913507951. View

20.

Vigneswara V, Kundi S, Ahmed Z . Receptor tyrosine kinases: molecular switches regulating CNS axon regeneration. J Signal Transduct. 2012; 2012:361721. PMC: 3405719. DOI: 10.1155/2012/361721. View